What drove BRN.AX stock higher pre-market today?

Pre-market buying reflected renewed interest in BrainChip’s Akida AI edge tech and short-term momentum. The stock was at **A$0.14**, up **+7.69%**, with news flow around partnerships and pilot deployments supporting demand.

How does Meyka forecast BRN.AX stock perform over the year?

Meyka AI's yearly forecast for BRN.AX stock is **A$0.17**, implying an **+18.75%** upside versus the current **A$0.14**. Forecasts are model-based projections and not guarantees.

What are the main risks for BRN.AX stock investors?

Key risks for BRN.AX stock include continued negative earnings, high price-to-sales valuation (**171.50**), execution risk for commercial rollouts, and volatile trading volumes that can amplify price swings.

When is the next earnings date for BRN.AX stock and why it matters?

BrainChip’s next earnings announcement is scheduled for **04 Mar 2026**. The report could update revenue guidance, cash position, and commercial milestones, which are key catalysts for BRN.AX stock direction.

AU Stocks

BRN.AX BrainChip (ASX) pre-market A$0.14 +7.69% 19 Feb 2026: AI edge catalyst

ByHuzaifa Zahoor February 18, 2026February 18, 2026

We start pre-market with BRN.AX stock at A$0.14, up +7.69% on 19 Feb 2026 as traders eye demand for low-power AI edge chips. BrainChip Holdings Ltd (BRN.AX) trades on the ASX with volume 2,768,879.00 and a market cap around A$318,391,868.00. This move ties to partner announcements and broader AI edge interest. Investors should weigh short-term technical strength against still-negative earnings and high volatility.